# Biotech Daily Digest â€” 2025-09-12

**20 items from 3 sources**

## Summary by Source

- Endpoints News: 6 items
- Fierce Biotech: 3 items
- arXiv q-bio: 11 items


## Endpoints News

- **[Pfizer has a VEGF bispecific strategy. And itâ€™s very different than Summitâ€™s](https://endpoints.news/pfizer-has-a-vegf-bispecific-strategy-and-its-very-different-than-summits/)**  
  _Fri, 12 Sep 2025 12:44:58 +0000_  
  As Wall Street continues to digest this weekâ€™s disappointing results for Summit Therapeuticsâ€™ PD-1xVEGF bispecific cancer drug, one competitor is primed to take advantage.

 Summitâ€™s stock {$SMMT} closed 20% lower on Monday ...

- **[Ousted FDA official joins Lilly; Novo names global research head as layoffs come into focus](https://endpoints.news/ousted-fda-official-joins-lilly-novo-names-global-research-head-as-layoffs-come-into-focus/)**  
  _Fri, 12 Sep 2025 11:00:45 +0000_  
  A former top cell and gene therapy regulator at the FDA is joining Eli Lilly in a policy role for the same therapeutic area.

 Rachael Anatol

- **[Novartis loses IRA appeals case](https://endpoints.news/novartis-loses-ira-appeals-case/)**  
  _Thu, 11 Sep 2025 18:09:37 +0000_  
  A federal appeals court on Thursday rejected Novartisâ€™ challenge against Medicare drug price negotiations, a week after tossing similar cases brought by Johnson & Johnson and Bristol Myers Squibb.

 The US Court of Appeals for ...

- **[Avidity shares fall after $500M offering, dimming hopes of a Novartis buyout](https://endpoints.news/avidity-shares-fall-after-500m-offering-dimming-hopes-of-a-novartis-buyout/)**  
  _Thu, 11 Sep 2025 15:19:21 +0000_  
  Is Avidity Biosciences signaling that it wonâ€™t be getting acquired any time soon?

 The company announced Wednesday afternoon that it's aiming to raise $500 million in a public offering on the ...

- **[LGC opens $72M chemical plant; Recipharm partners with NeuroSense](https://endpoints.news/lgc-opens-72m-chemical-plant-recipharm-partners-with-neurosense/)**  
  _Thu, 11 Sep 2025 15:12:39 +0000_  
  Welcome to Endpoints Newsâ€™ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

 LGC has opened its new $72 million facility in Ontario, Canada, the ...

- **[Mazeâ€™s SLC6A19 inhibitor moves to Phase 2; GenFleet to go public in Hong Kong](https://endpoints.news/mazes-slc6a19-inhibitor-moves-to-phase-2-genfleet-to-go-public-in-hong-kong/)**  
  _Thu, 11 Sep 2025 14:43:29 +0000_  
  ðŸ’° Maze Therapeuticsâ€™ stock soars on Phase 1 data, $150M raise: The company said the healthy volunteer data for its experimental treatment for phenylketonuria and chronic kidney disease support the plan ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/chutes-ladders-takeda-taps-longtime-lilly-exec-us-head" hreflang="en">Chutes &amp; Laddersâ€”Takeda taps longtime Lilly exec as US head</a>](https://www.fiercebiotech.com/biotech/chutes-ladders-takeda-taps-longtime-lilly-exec-us-head)**  
  _Sep 11, 2025 4:55pm_  
  With its head of U.S. business Julie Kim sliding up to the CEO spot next June, Takeda has locked in a replacement in Rhona Pacheco. Pacheco is set to leave behind her role as Eli Lillyâ€™s VP of U.S. cardiometabolic health, the most recent title sheâ€™s held along her 20-year tenure at Lilly which saw her overseeing the câ€¦

- **[<a href="https://www.fiercebiotech.com/pharma/amid-restructuring-novo-nordisk-orders-employees-return-office" hreflang="en">Amid restructuring, Novo Nordisk directs employees to return to office</a>](https://www.fiercebiotech.com/pharma/amid-restructuring-novo-nordisk-orders-employees-return-office)**  
  _Sep 11, 2025 2:17pm_  
  One day after announcing that it plans to cut 9,000 jobs in a major restructuring, Novo Nordisk has told its employees that office work will be mandatory at the start of next year.

- **[<a href="https://www.fiercebiotech.com/research/custom-gene-editor-fixes-mutation-causing-deadly-ultrarare-vascular-disease-mice" hreflang="en">Custom gene editor fixes mutation causing deadly ultrarare vascular disease in mice</a>](https://www.fiercebiotech.com/research/custom-gene-editor-fixes-mutation-causing-deadly-ultrarare-vascular-disease-mice)**  
  _Sep 11, 2025 1:16pm_  
  Researchers at Mass General Brigham in Boston have designed a custom gene editing technique that corrected the mutation behind a rare blood vessel disease in mice, paving the way for further development of the approach to treat the deadly condition and other genetic vascular diseases.


## arXiv q-bio

- **[Path to Intelligence: Measuring Similarity between Human Brain and Large Language Model Beyond Language Task](https://arxiv.org/abs/2509.08831)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.08831v1 Announce Type: new 
Abstract: Large language models (LLMs) have demonstrated human-like abilities in language-based tasks. While language is a defining feature of human intelligence, it emerges from more fundamental neurophysical processes rather than constituting the basis of intelligence itself. Iâ€¦

- **[A novel cost-effective fabrication of a flexible neural probe for brain signal recording](https://arxiv.org/abs/2509.09213)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.09213v1 Announce Type: new 
Abstract: This study introduces a novel, flexible, and implantable neural probe using a cost-effective microfabrication process based on a thin polyimide film. Polyimide film, known as Kapton, serves as a flexible substrate for microelectrodes, conductive tracks, and contact padsâ€¦

- **[Large deviations in non-Markovian stochastic epidemics](https://arxiv.org/abs/2509.09480)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.09480v1 Announce Type: new 
Abstract: We develop a framework for non-Markovian SIR and SIS models beyond mean field, utilizing the continuous-time random walk formalism. Using a gamma distribution for the infection and recovery inter-event times as a test case, we derive asymptotical late-time master equatiâ€¦

- **[LITcoder: A General-Purpose Library for Building and Comparing Encoding Models](https://arxiv.org/abs/2509.09152)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.09152v1 Announce Type: cross 
Abstract: We introduce LITcoder, an open-source library for building and benchmarking neural encoding models. Designed as a flexible backend, LITcoder provides standardized tools for aligning continuous stimuli (e.g., text and speech) with brain data, transforming stimuli intoâ€¦

- **[Incomplete Reputation Information and Punishment in Indirect Reciprocity](https://arxiv.org/abs/2509.09181)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.09181v1 Announce Type: cross 
Abstract: Indirect reciprocity promotes cooperation by allowing individuals to help others based on reputation rather than direct reciprocation. Because it relies on accurate reputation information, its effectiveness can be undermined by information gaps. We examine two forms oâ€¦

- **[Virtual staining for 3D X-ray histology of bone implants](https://arxiv.org/abs/2509.09235)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.09235v1 Announce Type: cross 
Abstract: Three-dimensional X-ray histology techniques offer a non-invasive alternative to conventional 2D histology, enabling volumetric imaging of biological tissues without the need for physical sectioning or chemical staining. However, the inherent greyscale image contrastâ€¦

- **[Fused Lasso Improves Accuracy of Co-occurrence Network Inference in Grouped Samples](https://arxiv.org/abs/2509.09413)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.09413v1 Announce Type: cross 
Abstract: Co-occurrence network inference algorithms have significantly advanced our understanding of microbiome communities. However, these algorithms typically analyze microbial associations within samples collected from a single environmental niche, often capturing only statâ€¦

- **[bioSBM: a random graph model to integrate epigenomic data in chromatin structure prediction](https://arxiv.org/abs/2409.14425)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2409.14425v2 Announce Type: replace 
Abstract: The spatial organization of chromatin within the nucleus plays a crucial role in gene expression and genome function. However, the quantitative relationship between this organization and nuclear biochemical processes remains under debate. In this study, we present aâ€¦

- **[Knowledge-Guided Biomarker Identification for Label-Free Single-Cell RNA-Seq Data: A Reinforcement Learning Perspective](https://arxiv.org/abs/2501.04718)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2501.04718v2 Announce Type: replace 
Abstract: Gene panel selection aims to identify the most informative genomic biomarkers in label-free genomic datasets. Traditional approaches, which rely on domain expertise, embedded machine learning models, or heuristic-based iterative optimization, often introduce biasesâ€¦

- **[SurGBSA: Learning Representations From Molecular Dynamics Simulations](https://arxiv.org/abs/2509.03084)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2509.03084v2 Announce Type: replace 
Abstract: Self-supervised pretraining from static structures of drug-like compounds and proteins enable powerful learned feature representations. Learned features demonstrate state of the art performance on a range of predictive tasks including molecular properties, structureâ€¦

- **[Inferring entropy production in many-body systems using nonequilibrium MaxEnt](https://arxiv.org/abs/2505.10444)**  
  _Fri, 12 Sep 2025 00:00:00 -0400_  
  arXiv:2505.10444v3 Announce Type: replace-cross 
Abstract: We propose a method for inferring entropy production (EP) in high-dimensional stochastic systems, including many-body systems and non-Markovian systems with long memory. Standard techniques for estimating EP become intractable in such systems due to computatioâ€¦
